Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study

Identifieur interne : 002C08 ( Main/Exploration ); précédent : 002C07; suivant : 002C09

---

Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study

Auteurs : Jang-Jaer Lee [Taïwan] ; Shih-Jung Cheng [Taïwan] ; Jai-Jen Wang [Taïwan] ; Chun-Pin Chiang [Taïwan] ; Hao-Hueng Chang [Taïwan] ; Hsin-Ming Chen [Taïwan] ; Sang-Heng Kok [Taïwan]

Source :

• Head & Neck [ 1043-3074 ] ; 2013-12.

RBID : ISTEX:C2C0B6B18F602D840DB14B1C94225B43303DF96E

Descripteurs français

• Wicri :
  • topic : Chiffre d'affaires.

English descriptors

• KwdEn :
  • Adjunctive therapy, Alcohol drinking, Alendronate, Alendronate therapy, Alkaline phosphatase, American association, Anterior lesion length, Anterior lesions, Better prognosis, Biochemical markers, Bisphosphonate, Bisphosphonate treatment, Bisphosphonaterelated osteonecrosis, Bisphosphonates, Bone destruction area, Bone formation, Bone mineral density, Bone necrosis, Bone resorption, Bone turnover, Bronj, Bronj diagnosis, Bronj lesions, Bronj patients, Bsap, Bsap level, Bsap levels, Cancer chemotherapy, Cancer patients, Certain period, Chlorhexidine mouth rinse, Clinical factors, Clinical variables, Complete response, Confidence interval, Cumulative dose, December, Deeper extension, Diabetes mellitus, Disease stage, Drug holiday, Drug therapy, Drug treatment, Event dentoalveolar surgery, Hazard ratio, Head december, Head neck, Healing period, Healing time, Higher pretreatment level, Intravenous bisphosphonates, Lesion, Lesion depth, Lesion length, Lesion resolution, Lesion site lesion depth, Lesion site maxilla mandible lesion site, Mandible, Maxillofac, Maxillofacial surgeons, Maxillofacial surgery, Median, Medical comorbidities, Multivariate analyses, Multivariate analysis, National taiwan university, National taiwan university hospital, Oral alendronate, Oral bisphosphonate, Oral bisphosphonate therapy, Oral bisphosphonates, Oral maxillofac surg, Oral oncol, Oral pathol, Oral surg, Osteonecrosis, Osteoporosis, Osteoporotic, Osteoporotic patients, Parathyroid hormone, Pathologic fracture, Pearson correlation coefficient, Phosphatase, Postmenopausal osteoporosis, Postmenopausal women, Present study, Pretreatment, Pretreatment serum bsap, Previous studies, Prognosis, Prognostic, Prognostic figure, Prognostic indicators, Prognostic values, Radiol endod, Risk factors, Serum bsap, Serum bsap level, Serum level, Serum markers, Significant difference, Surg, Surgical, Surgical therapy, Surgical treatment, Teriparatide, Treatment modalities, Treatment outcome, Treatment outcomes, Treatment period, True extent, Turnover, Uninvolved bone.
• Teeft :
  • Adjunctive therapy, Alcohol drinking, Alendronate, Alendronate therapy, Alkaline phosphatase, American association, Anterior lesion length, Anterior lesions, Better prognosis, Biochemical markers, Bisphosphonate, Bisphosphonate treatment, Bisphosphonaterelated osteonecrosis, Bisphosphonates, Bone destruction area, Bone formation, Bone mineral density, Bone necrosis, Bone resorption, Bone turnover, Bronj, Bronj diagnosis, Bronj lesions, Bronj patients, Bsap, Bsap level, Bsap levels, Cancer chemotherapy, Cancer patients, Certain period, Chlorhexidine mouth rinse, Clinical factors, Clinical variables, Complete response, Confidence interval, Cumulative dose, December, Deeper extension, Diabetes mellitus, Disease stage, Drug holiday, Drug therapy, Drug treatment, Event dentoalveolar surgery, Hazard ratio, Head december, Head neck, Healing period, Healing time, Higher pretreatment level, Intravenous bisphosphonates, Lesion, Lesion depth, Lesion length, Lesion resolution, Lesion site lesion depth, Lesion site maxilla mandible lesion site, Mandible, Maxillofac, Maxillofacial surgeons, Maxillofacial surgery, Median, Medical comorbidities, Multivariate analyses, Multivariate analysis, National taiwan university, National taiwan university hospital, Oral alendronate, Oral bisphosphonate, Oral bisphosphonate therapy, Oral bisphosphonates, Oral maxillofac surg, Oral oncol, Oral pathol, Oral surg, Osteonecrosis, Osteoporosis, Osteoporotic, Osteoporotic patients, Parathyroid hormone, Pathologic fracture, Pearson correlation coefficient, Phosphatase, Postmenopausal osteoporosis, Postmenopausal women, Present study, Pretreatment, Pretreatment serum bsap, Previous studies, Prognosis, Prognostic, Prognostic figure, Prognostic indicators, Prognostic values, Radiol endod, Risk factors, Serum bsap, Serum bsap level, Serum level, Serum markers, Significant difference, Surg, Surgical, Surgical therapy, Surgical treatment, Teriparatide, Treatment modalities, Treatment outcome, Treatment outcomes, Treatment period, True extent, Turnover, Uninvolved bone.

Abstract

Url:

• https://api.istex.fr/document/C2C0B6B18F602D840DB14B1C94225B43303DF96E/fulltext/pdf

DOI: 10.1002/hed.23235

Affiliations:

• Taïwan

---

Links toward previous steps (curation, corpus...)

• to stream Istex, to step Corpus: 006086
• to stream Istex, to step Curation: 006086
• to stream Istex, to step Checkpoint: 000761
• to stream Main, to step Merge: 002C20
• to stream Main, to step Curation: 002C08

---

Le document en format XML

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/EdenteV2/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002C08 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002C08 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    EdenteV2
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     ISTEX:C2C0B6B18F602D840DB14B1C94225B43303DF96E
   |texte=   Factors predicting the prognosis of oral alendronate‐related osteonecrosis of the jaws: A 4‐year cohort study
}}

---

This area was generated with Dilib version V0.6.32. Data generation: Thu Nov 30 15:26:48 2017. Site generation: Tue Mar 8 16:36:20 2022